Trial Profile
Liraglutide compared with Linagliptin and Vildagliptin in patients with Type II Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Oct 2018
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Linagliptin; Vildagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 05 Oct 2018 Results (n=243) assessing the effect of liraglutide compared to linagliptin and vildagliptin for nephroprotection through an impact on factors of angiopathy, presented at the 54th Annual Meeting of the European Association for the Study of Diabetes
- 22 Sep 2016 New trial record